We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Near Infrared Light Delivered Transcranially Can Treat Traumatic Brain Injury

By HospiMedica International staff writers
Posted on 14 Oct 2024

Mild traumatic brain injury (mTBI) occurs when the initial head trauma is compounded by a series of inflammatory changes in the brain, known as secondary processes, which can worsen patient outcomes significantly. More...

These processes begin within minutes to hours after the injury. Now, researchers have demonstrated that light therapy, delivered transcranially (through the skull), can support tissue repair following mTBI. Their study, published in Bioengineering & Translational Medicine, suggests that this innovative approach could offer a new treatment option in a field where there are currently few available therapies.

Developed by scientists at the University of Birmingham (Birmingham, UK), the technique aims to protect against secondary damage and promote quicker and more effective recovery. Their research builds on earlier findings that demonstrated the benefits of near-infrared light therapy in improving nerve cell survival and stimulating new nerve growth at the site of spinal cord injury. In the latest study, the researchers investigated the effects of two wavelengths of near-infrared light (660nm and 810nm) on recovery in preclinical models. The treatment involved two-minute bursts of infrared light administered daily for three days post-injury.

The results revealed significant reductions in the activation of astrocytes and microglial cells, which play key roles in the brain's inflammatory response after trauma, along with a decrease in markers of apoptosis (cell death). After four weeks, there were notable improvements in functional tests related to balance and cognitive performance. Red light therapy also sped up recovery compared to control groups, with the 810nm wavelength showing superior outcomes. The researchers are now looking for commercial partners to help co-develop and bring this device to market.

“We want to develop this method into a medical device that can be used to enhance recovery for patients with traumatic brain or spinal cord injury, with the aim of improving outcomes for patients,” said Zubair Ahmed, Professor at the University of Birmingham, who led the study.


Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Absorbable Monofilament Mesh
Phasix Mesh
New
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.